Drug price mechanisms ‘work against’ buyers: Included Health CEO


President Trump unveiled his plans for sweeping healthcare policy on Thursday, which includes lowering drug prices and health insurance premiums as Americans continue to voice concerns of a growing affordability crisis.

Included Health CEO Owen Tripp illustrates how the US healthcare system is far from operating at its best, commenting on drug price mechanisms and how he would fix the system.

Also catch Owen Tripp’s opinions on the integration of AI in medical systems and its exposure to personal data.

To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.



Source link

  • Related Posts

    Former Miss Hall’s School teacher faces rape charges in court

    PITTSFIELD, Mass. — The two women who led the charge to expose sexual abuse at a posh Massachusetts boarding and day school for girls say they will be in the…

    Rogers slashes capital spending as it blames regulations, reports Q1 profit up

    TORONTO — Rogers Communications Inc. is cutting its capital spending by 30 per cent compared with last year, citing a “punitive” regulatory environment and competitive pressures. In its outlook, Rogers…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    How many pampered hikers can you freeze in alpine tycoon game Above the Snow?

    How many pampered hikers can you freeze in alpine tycoon game Above the Snow?

    2026 NFL mock draft: Giants bypass wide receiver in Round 1

    2026 NFL mock draft: Giants bypass wide receiver in Round 1

    Up to 50 cm of snow forecast for parts of Saskatchewan, Manitoba

    Up to 50 cm of snow forecast for parts of Saskatchewan, Manitoba

    Former Miss Hall’s School teacher faces rape charges in court

    Former Miss Hall’s School teacher faces rape charges in court

    The 8 Best Vintage Stores in Tokyo, Japan, to Visit

    The 8 Best Vintage Stores in Tokyo, Japan, to Visit

    Breast cancer type study 'critically under-funded'

    Breast cancer type study 'critically under-funded'